MOTS-C
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c)
A mitochondria-derived peptide studied for its proposed role in cellular energy regulation and metabolic signaling.
What Is MOTS-C?
Why Is MOTS-C Being Studied?
- Mitochondrial-to-nuclear signaling
- Insulin sensitivity and glucose metabolism
- Exercise adaptation research
- Cellular stress response pathways
How Does It Work?
MOTS-c is proposed to act as a signaling molecule that communicates mitochondrial status to the cell nucleus, potentially influencing gene expression related to metabolism and stress response. Researchers have studied its relationship to AMPK, a cellular energy-sensing pathway, in laboratory models.
MOTS-c
Mitochondrial-nuclear signaling & AMPK pathway
Metabolic gene expression changes
Energy metabolism outcomes studied in animal models
What Does The Evidence Say?
Human Research
Human research on MOTS-c is limited and largely exploratory, with some small observational studies examining circulating MOTS-c levels in relation to exercise and metabolic markers.
Preclinical Research
Animal studies have examined MOTS-c's effects on insulin sensitivity, exercise capacity, and metabolic markers, forming the primary evidence base for this peptide.
What We Don't Know Yet
Whether administering MOTS-c as a therapy produces meaningful effects in humans, and what safe, effective dosing might look like, have not been established through clinical trials.
Areas of Research
Cellular Energy
MOTS-c's origin in mitochondrial DNA has driven research interest in cellular energy regulation.
Metabolic Health
Animal studies have examined relationships between MOTS-c and insulin sensitivity.
Longevity
Mitochondrial signaling research often intersects with broader aging and longevity science.
Why Might Someone Discuss This With Their Provider?
Someone interested in mitochondrial biology, metabolism, or longevity science may encounter MOTS-c while researching cellular energy pathways.
Whether a therapy is appropriate depends on individual health history, medications, goals and clinician evaluation.
Important Considerations
MOTS-c is not approved by the FDA for any medical use and is not an FDA-approved drug product.
Evidence is primarily preclinical and derived from animal models. Human clinical data is limited. Discuss any interest in mitochondrial-targeted peptides with a licensed healthcare provider.
Related Peptides
NAD+
A naturally occurring coenzyme central to cellular energy production, studied for its relationship to fatigue, aging, and metabolic function.
Tesamorelin
A growth hormone releasing hormone analog with a narrow FDA-approved indication for visceral fat reduction in a specific patient population.
Research & References
No references have been added for this entry yet. This library is updated on an ongoing basis.
The Peptide User Guide is provided for educational purposes and is not intended to diagnose, treat, cure, prevent, or provide individualized medical advice. Research surrounding many peptides and investigational therapies continues to evolve, and the strength of evidence varies significantly between compounds and applications. Treatment decisions should be made in consultation with a qualified healthcare professional.